SMCHD1 and arhinia, choanal atresia, and microphthalmia: While in most BAMS patients mutations induce gain of ATPase activity, there is a loss of function in FSHD2 regarding remethylation [59] (see “The ATPase domain of BAMS and FSHD2”).